During the past decade, Community Cancer Center of Monroe conducted 18 clinical trials. In the 10-year time frame, 18 clinical trials started and 90 clinical trials were completed, i.e. on average, 500% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 26 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Community Cancer Center of Monroe" #1 sponsor was "Alliance for Clinical Trials in Oncology" with 70 trials, followed by "SWOG Cancer Research Network" with 27 trials sponsored, "National Cancer Institute (NCI)" with 23 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 12 trials sponsored and "Eastern Cooperative Oncology Group" with 12 trials sponsored. Other sponsors include 10 different institutions and companies that sponsored additional 14 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Community Cancer Center of Monroe" #1 collaborator was "National Cancer Institute (NCI)" with 132 trials as a collaborator, "NCIC Clinical Trials Group" with 12 trials as a collaborator, "Cancer and Leukemia Group B" with 7 trials as a collaborator, "Eastern Cooperative Oncology Group" with 4 trials as a collaborator and "North Central Cancer Treatment Group" with 4 trials as a collaborator. Other collaborators include 21 different institutions and companies that were collaborators in the rest 23 trials.

According to Clinical.Site data, the most researched conditions in "Community Cancer Center of Monroe" are "Breast Cancer" (34 trials), "Lung Cancer" (15 trials), "Unspecified Adult Solid Tumor, Protocol Specific" (14 trials), "Recurrent Squamous Cell Lung Carcinoma" (9 trials) and "Lymphoma" (8 trials). Many other conditions were trialed in "Community Cancer Center of Monroe" in a lesser frequency.

Most popular intervention types in "Community Cancer Center of Monroe" are "Drug" (128 trials), "Other" (75 trials), "Biological" (52 trials), "Procedure" (19 trials) and "Radiation" (14 trials). Other intervention types were less common.

The name of intervention was led by "placebo" (32 trials), "Laboratory Biomarker Analysis" (25 trials), "bevacizumab" (13 trials), "cetuximab" (12 trials) and "Quality-of-Life Assessment" (9 trials). Other intervention names were less common.

The vast majority of trials in "Community Cancer Center of Monroe" are 121 trials for "All" genders, 31 trials for "Female" genders and 4 trials for "Male" genders.

Currently, there are NaN active trials in "Community Cancer Center of Monroe". undefined are not yet recruiting, 4 are recruiting, 32 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 108 completed trials in Community Cancer Center of Monroe, undefined suspended trials, and 10 terminated clinical trials to date.

Out of the total trials that were conducted in Community Cancer Center of Monroe, 4 "Phase 1" clinical trials were conducted, 68 "Phase 2" clinical trials and 77 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".